EUVIMEDEUVIMED entdecken
Crossref

Application of LEF-1 immunohistochemical staining in the diagnosis of solid pseudopapillary neoplasm of the pancreas

Saroja Devi Geetha, Atif Khan, Anam Khan, Yonah Ziemba, Karen Chau, Sunder Sham, Silvat Sheikh-Fayyaz, Arvind Rishi, Deepika Savant

Pathology - Research and Practice · 2024

DOI: 10.1016/j.prp.2024.155662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Saroja Devi Geetha und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, North Shore University Hospital and Long Island Jewish Medical Center, Donald and Barbara Zucker Sch…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Lymphoid Enhancer-Binding Factor 1, Immunohistochemistry, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Solid pseudopapillary neoplasm (SPN) is a tumor of young females with gain-of-function mutation in catenin beta 1 gene involved in Wnt signal transduction pathway. Beta-catenin immunohistochemistry (IHC) is used to diagnose SPN. Lymphoid enhancer-binding factor 1 (LEF-1) has been recognized in the transactivation of Wnt pathway. We aim to study LEF-1 IHC in SPN and other pancreatic tumors and compare it with beta-catenin IHC. METHODS: We retrieved cases of SPN, pancreatic neuroendocrine tumor (PanNET), serous cystadenoma (SCA), ductal adenocarcinoma (PDAC) and acinar cell carcinoma (ACC) from 2011 to 2023. Formalin-fixed, paraffin-embedded blocks with adequate tumor were cut and stained with beta-catenin (B-Catenin-1 clone) and LEF-1 (EP310 clone) IHC. Cases were reviewed by two pathologists independently. Nuclear staining with LEF-1 and beta-catenin was considered as positive. RESULTS: Our cohort consisted of 111 cases [SPN = 59 (42 resections, 11 FNA, 6 biopsies), PDAC = 24, PanNET = 22, SCA = 5, ACC = 1]. For SPN cases male to female ratio was1:8. Age ranged from 9 to 81 years (average: 32 years). Pancreatic tail was the most common location (47 %) followed by head (28 %), body (19 %) and neck (6 %). Tumor size ranged from 1.0 to 12.2 cm (average: 5 cm). Among the SPN cases 57/59 demonstrated strong nuclear LEF-1 staining. 2/49 cases were negative for LEF-1 (both pathologist in agreement). All SPN tumors demonstrated nuclear staining with beta-catenin. Among the non-SPN tumors, beta-catenin showed nuclear staining in 2/52 cases (2 PDAC). The remaining 50 cases were negative for nuclear beta-catenin and demonstrated variable staining pattern with interpretation variability between the two pathologists. The sensitivity and specificity for LEF-1 were 97 % and 100 %, respectively, while for beta-catenin, they were 100 % and 96 % respectively. CONCLUSION: Crisp nuclear staining of LEF-1 without background staining makes diagnostic interpretation relatively easy and accurate compared to beta-catenin IHC. This is further helpful for small biopsy samples to help differentiate SPN from mimickers such as PanNET. None of the non-SPN cases displayed nuclear LEF-1 rendering it a valuable adjunct to beta-catenin in the diagnostic evaluation of SPN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsLymphoid Enhancer-Binding Factor 1ImmunohistochemistryBiomarkers, Tumorbeta CateninHumansFemaleMaleAdultMiddle AgedYoung AdultAdolescentAgedChildCarcinoma, Acinar CellCarcinoma, PapillaryCarcinoma, Pancreatic Ductal

Stichwörter der Autor:innen

Beta-cateninLEF-1 IHCPancreatic cancerPancreatic neoplasmSolid pseudopapillary neoplasm

Substanzen

Lymphoid Enhancer-Binding Factor 1LEF1 protein, humanBiomarkers, Tumorbeta CateninCTNNB1 protein, human

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, North Shore University Hospital and Long Island Jewish Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health, United States. Electronic…
  • Department of Pathology and Laboratory Medicine, North Shore University Hospital and Long Island Jewish Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health, United States.
  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, NY, United States.

Zitieren

APA

Geetha, S. D., Khan, A., Khan, A., Ziemba, Y., Chau, K., Sham, S., Sheikh-Fayyaz, S., Rishi, A., & Savant, D. (2024). Application of LEF-1 immunohistochemical staining in the diagnosis of solid pseudopapillary neoplasm of the pancreas. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155662

Vancouver

Geetha SD, Khan A, Khan A, Ziemba Y, Chau K, Sham S, et al. Application of LEF-1 immunohistochemical staining in the diagnosis of solid pseudopapillary neoplasm of the pancreas. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155662

BibTeX
@article{Geetha2024,
  author = {Geetha, Saroja Devi and Khan, Atif and Khan, Anam and Ziemba, Yonah and Chau, Karen and Sham, Sunder and Sheikh-Fayyaz, Silvat and Rishi, Arvind and Savant, Deepika},
  title = {Application of LEF-1 immunohistochemical staining in the diagnosis of solid pseudopapillary neoplasm of the pancreas},
  journal = {Pathology - Research and Practice},
  year = {2024},
  doi = {10.1016/j.prp.2024.155662}
}
Kostenlos starten →